Montai Therapeutics
Cambridge, United States· Est. 2021
Harnessing untapped diverse chemistry with AI-enabled drug discovery to develop breakthrough small molecule medicines for chronic disease.
Private Company
Total funding raised: $33M
About
Harnessing untapped diverse chemistry with AI-enabled drug discovery to develop breakthrough small molecule medicines for chronic disease.
AI / Machine LearningSmall Molecules
Funding History
2Total raised:$33M
Series A$25MMay 15, 2023
Seed$8MJan 15, 2022